Krivak TC

No ORCID on file · 3 papers in corpus
2012
Differential analysis of ovarian and endometrial cancers identifies a methylator phenotype.
PloS one ·doi:10.1371/journal.pone.0032941

Despite improved outcomes in the past 30 years, less than half of all women diagnosed with epithelial ovarian cancer live five years beyond their diagnosis. Although typically treated as a single disease, epithelial ovarian cancer includes …

2011
Proteomic analysis of ovarian cancer proximal fluids: validation of elevated peroxiredoxin 1 in patient peripheral circulation.
PloS one ·doi:10.1371/journal.pone.0025056

BackgroundEpithelial ovarian cancer (EOC) is the deadliest gynecologic malignancy in the United States. Unfortunately, a validated protein biomarker-screening test to detect early stage disease from peripheral blood has not yet been develop…

2009
A Gynecologic Oncology Group Study of serum CA-125 levels in patients with stage III optimally debulked ovarian cancer treated with intraperitoneal compared to intravenous chemotherapy: an analysis of patients enrolled in GOG 172.
Gynecologic Oncology ·doi:10.1016/j.ygyno.2009.06.021

ObjectiveSerum CA-125 values have been advocated in the monitoring of ovarian cancer patients receiving intravenous (IV) chemotherapy. This evaluation sought to determine if the CA-125 test can be used to monitor treatment effect among pati…